IL141611A0 - Thiazoline acid derivatives - Google Patents

Thiazoline acid derivatives

Info

Publication number: IL141611A0
Authority: IL; Israel
Prior art keywords: acid derivatives; thiazoline acid; thiazoline; diagnosing; pyridyl
Prior art date: 1998-08-31

Application number

IL14161199A

Other languages

English (en)

Original Assignee

Univ Florida

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-08-31

Filing date

1999-08-31

Publication date

2002-03-10

1999-08-31 Application filed by Univ Florida filed Critical Univ Florida

2002-03-10 Publication of IL141611A0 publication Critical patent/IL141611A0/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/04—Chelating agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Epidemiology (AREA)
Physical Education & Sports Medicine (AREA)
Diabetes (AREA)
Obesity (AREA)
Hematology (AREA)
Toxicology (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Gastroenterology & Hepatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Thiazole And Isothizaole Compounds (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Game Rules And Presentations Of Slot Machines (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Pyrrole Compounds (AREA)

IL14161199A 1998-08-31 1999-08-31 Thiazoline acid derivatives IL141611A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US09/144,103 US6083966A (en)	1998-08-31	1998-08-31	Thiazoline acid derivatives
PCT/US1999/019691 WO2000012493A1 (en)	1998-08-31	1999-08-31	Thiazoline acid derivatives

Publications (1)

Publication Number	Publication Date
IL141611A0 true IL141611A0 (en)	2002-03-10

Family

ID=22507049

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IL14161199A IL141611A0 (en)	1998-08-31	1999-08-31	Thiazoline acid derivatives
IL141611A IL141611A (en)	1998-08-31	2001-02-22	History of thiazoline acid, optical antipodes, rheumatoids, salts and their pharmaceutical preparations in the preparation of drugs for the prevention and treatment of pathological diseases

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IL141611A IL141611A (en)	1998-08-31	2001-02-22	History of thiazoline acid, optical antipodes, rheumatoids, salts and their pharmaceutical preparations in the preparation of drugs for the prevention and treatment of pathological diseases

Country Status (23)

Country	Link
US (9)	US6083966A (sh)
EP (1)	EP1109795B1 (sh)
JP (3)	JP4817498B2 (sh)
KR (1)	KR20010074907A (sh)
CN (1)	CN100455574C (sh)
AT (1)	ATE317392T1 (sh)
AU (1)	AU759851B2 (sh)
BR (1)	BR9913441B1 (sh)
CA (1)	CA2342210C (sh)
CZ (1)	CZ2001711A3 (sh)
DE (1)	DE69929807T2 (sh)
EA (1)	EA200100261A1 (sh)
ES (1)	ES2260933T3 (sh)
HU (1)	HUP0103165A3 (sh)
IL (2)	IL141611A0 (sh)
NO (1)	NO321028B1 (sh)
NZ (1)	NZ509899A (sh)
PL (1)	PL346852A1 (sh)
PT (1)	PT1109795E (sh)
TR (1)	TR200100541T2 (sh)
UA (1)	UA57161C2 (sh)
WO (1)	WO2000012493A1 (sh)
YU (1)	YU21801A (sh)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6083966A (en) *	1998-08-31	2000-07-04	University Of Florida	Thiazoline acid derivatives
CN1585639A (zh) *	1998-09-21	2005-02-23	佛罗里达大学研究基金会	抗疟疾制剂
EP1488791A3 (en) *	1998-09-21	2005-04-06	University Of Florida Research Foundation, Inc.	Antimalarial agents
US6806363B1 (en) *	1999-04-16	2004-10-19	Mayo Foundation For Medical Education & Research	Cobalamin conjugates useful as antitumor agents
AU785505B2 (en)	1999-10-15	2009-02-26	Mayo Foundation For Medical Education And Research	Cobalamin conjugates useful as imaging and therapeutic agents
US6689788B1 (en) *	2000-08-25	2004-02-10	University Of Florida	Method and composition for treatment of inflammatory bowel disease
TWI228512B (en) *	2000-10-25	2005-03-01	Mayo Foundation	Transcobalamin binding conjugates useful for treating abnormal cellular proliferation
EP1506162B1 (en) *	2002-05-15	2008-11-26	Genzyme Corporation	Synthesis of benzonitriles and benzimidates
US20040044220A1 (en) *	2002-08-22	2004-03-04	University Of Florida	Antioxidant and radical scavenging activity of synthetic analogs of desferrithiocin
WO2004017959A2 (en) *	2002-08-22	2004-03-04	University Of Florida	Antioxidant and radical scavenging activity of synthetic analogs of desferrithiocin
US20060069134A1 (en) *	2002-10-01	2006-03-30	Kaneka Corporation	Process for producing optically active alpha-substituted cysteine or salt thereof, intermediate therefor, and process for producing the same
US20040185028A1 (en) *	2003-03-19	2004-09-23	Zhenze Hu	Antimicrobial compositions containing ethanolamine buffer and biguanide disinfectant
WO2005023310A2 (en) *	2003-09-09	2005-03-17	University Of Florida Research Foundation, Inc.	Polyamine-metal chelator conjugates
AU2003270473A1 (en) *	2003-09-09	2005-04-27	University Of Florida	Desferrithiocin derivatives and their use as iron chelators
WO2005055931A2 (en) *	2003-12-03	2005-06-23	University Of Medicine And Dentistry Of New Jersey	Method of preventing survival of retrovirally cells and of inhibiting formation of infectious retroviruses
WO2005075475A1 (ja) *	2004-02-04	2005-08-18	Shionogi & Co., Ltd.	Ｈｉｖインテグラーゼ阻害活性を有するナフチリジン誘導体
BRPI0610644B8 (pt) *	2005-04-04	2021-05-25	Univ Florida	composto e composição farmacêutica que compreende tal composto e um veículo ou diluente farmaceuticamente aceitável.
US7365371B2 (en)	2005-08-04	2008-04-29	Cree, Inc.	Packages for semiconductor light emitting devices utilizing dispensed encapsulants
CA2684837A1 (en) *	2006-12-12	2008-10-30	Raymond J. Bergeron, Jr.	Desferrithiocin analogue actinide decorporation agents
NZ579994A (en)	2007-03-15	2011-09-30	Univ Florida	Desferrithiocin polyether analogues useful in the treatment of pathological conditions responsive to chelation or sequestration of trivalent metal
NZ590302A (en) *	2008-07-14	2013-02-22	Ferrokin Biosciences Inc	Novel salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agents
CA2798082A1 (en)	2010-05-04	2011-11-10	Shire Llc	Desazadesferrothiocin analogues as metal chelation agents
CN103562379A (zh) *	2011-05-19	2014-02-05	国立大学法人德岛大学	细胞分化诱导剂以及分化诱导方法
EP2790697B1 (en)	2011-12-16	2019-10-23	University of Florida Research Foundation, Inc.	Uses of 4'-desferrithiocin analogs
JP6353751B2 (ja) *	2013-09-25	2018-07-04	国立大学法人電気通信大学	新規複素環式化合物及びその塩、並びに、発光基質組成物
WO2015077655A1 (en)	2013-11-22	2015-05-28	University Of Florida Research Foundation, Inc.	Desferrithiocin analogs and uses thereof
WO2016176343A1 (en)	2015-04-27	2016-11-03	University Of Florida Research Foundation, Incorporated	Metabolically programmed metal chelators and uses thereof

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3274207A (en)		1966-09-20		Processes for preparing thiazole carboxylic acids
US3809754A (en)	1968-12-31	1974-05-07	Medial De Toledo & Cie	Method of treating diseases of the mucous membrane using compounds of a thiazolidine carboxylic acid and pharmaceutical preparations thereof
US3882110A (en)	1969-06-11	1975-05-06	Roussel Uclaf	Novel 2-alkyl-5-thiazole-carboxylic acid derivatives
DE2045818A1 (de)	1969-09-17	1971-04-08	Godo Shusei Kabushiki Kaisha, Tokio	Aeruginoinsäure und Verfahren zu ihrer Herstellung
FR2062120A5 (sh)	1969-10-10	1971-06-25	Messier Fa
FR2141526B1 (sh)	1971-06-14	1975-05-30	Roussel Uclaf
DE2245560A1 (de)	1972-09-16	1974-03-21	Basf Ag	Verfahren zur herstellung von 4alkoxycarbonyl-2-thiazolinen
US4430344A (en)	1978-04-08	1984-02-07	Santen Pharmaceutical Co., Ltd.	Antihypertensive 4-thiazolidinecarboxylic acids
CS205217B1 (cs)	1979-04-05	1981-05-29	Zdenek Vitamvas	Dozimetr ionizujícího záření
DE3002989A1 (de)	1980-01-29	1981-07-30	Hoechst Ag, 6000 Frankfurt	Hydroxyphenyl-thiazol, -thiazolin und -thiazolidin-carbonsaeuren, verfahren zu ihrer herstellung und ihre verwendung zur beeinflussung des kollagenstoffwechsels
ZA815129B (en) *	1980-07-28	1982-07-28	Ciba Geigy Ag	Thiazoline derivatives and processes for their manufacture
DE3170401D1 (en) *	1980-07-28	1985-06-13	Ciba Geigy Ag	Triazoline derivatives and processes for their preparation
JPS5772975A (en)	1980-10-24	1982-05-07	Kureha Chem Ind Co Ltd	2-substituted phenylthiazole derviative, and medicine for peptic ulcer containing said derivative as active component
US4367233A (en)	1981-10-02	1983-01-04	American Home Products Corporation	Inhibitors of mammalian collagenase
EP0226591B1 (en)	1984-12-18	1992-09-23	Clark Pharmaceutical Development, Ltd.	Anti-tumor compositions containing the reaction product of a cytotoxic aldehyde with penicillamine and their use for the manufacture of medicaments
HU200177B (en)	1985-06-18	1990-04-28	Biogal Gyogyszergyar	Process for producing thiazolidinecarboxylic acids and pharmaceutical compositions comprising such compounds
US4736060A (en)	1985-08-06	1988-04-05	Nippon Rikagakuyakuhin Co., Ltd.	Method for optical resolution of DL-cysteine and (R,S)-1-(1-naphthyl) ethylamine
EP0214933A3 (de)	1985-09-03	1989-05-24	Ciba-Geigy Ag	Kombinationspräparate zur Behandlung von Malaria
EP0214101A3 (de)	1985-09-03	1989-05-31	Ciba-Geigy Ag	Verwendung von Eisen(III)-Chelatoren vom Typ Desferrioxamin B und Desferriferrithiocin zur Behandlung von Malaria
JPS62142168A (ja)	1985-10-16	1987-06-25	Mitsubishi Chem Ind Ltd	チアゾ−ル誘導体及びそれを有効成分とするロイコトリエンきつ抗剤
DE3735757A1 (de)	1987-10-22	1989-05-03	Degussa	Optisch aktive salze aus einem substituierten thiazolidin-4-carboxylat und 3-chlor-2-hydroxypropyltrimethylammonium, deren herstellung und verwendung
DE58906384D1 (de)	1988-01-20	1994-01-27	Ciba Geigy	Verfahren zur Herstellung von Komplexverbindungen.
GB8826035D0 (en)	1988-11-07	1988-12-14	Ici Plc	Herbicidal compositions
US5182402A (en)	1988-11-07	1993-01-26	Imperial Chemical Industries Plc	Herbicidal compositions
US5106992A (en)	1989-07-28	1992-04-21	E. R. Squibb & Sons, Inc.	3,5-dihydroxypentanoic acid derivatives useful as antihypercholesterolemic agents and method for preparing same
NL9001955A (nl)	1990-09-05	1992-04-01	Cedona Pharm Bv	Nieuwe thiazolidinederivaten.
US5393777A (en)	1990-11-15	1995-02-28	State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon Health Sciences University	Deferration using anguibactin siderophore
ES2245660T3 (es)	1990-11-30	2006-01-16	Otsuka Pharmaceutical Co., Ltd.	Derivados de azol y su utilizacion como inhibidores de los radicales superoxidos.
WO1992009279A1 (fr)	1990-11-30	1992-06-11	Teijin Limited	Derive de 2-arylthiazole et composition pharmaceutique contenant ce derive
FR2677021B1 (fr)	1991-05-31	1993-10-01	Upsa Laboratoires	Nouveaux derives de thiazole antagonistes des recepteurs a l'angiotensine ii; leurs procedes de preparation, compositions pharmaceutiques les contenant.
US5840739A (en) *	1992-11-16	1998-11-24	University Of Florida Research Foundation, Inc.	Thiazoline acid derivatives
WO1994011367A1 (en) *	1992-11-16	1994-05-26	University Of Florida Research Foundation Inc.	2-(pyrid-2'-yl)-2-thiazoline-4(s)-carboxylic acid derivatives
DE4301356A1 (de)	1993-01-20	1994-07-21	Basf Ag	Verfahren zur Herstellung von 2-Alkyl-4-fluormethyl-thiazolcarbonsäure-alkylestern
FR2749583B1 (fr)	1996-06-07	1998-08-21	Lipha	Nouveaux derives de thiazolidine -2,4- dione substitues, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant
US20020049316A1 (en)	1997-04-29	2002-04-25	Halbert Stacie Marie	Protease inhibitors
US6373912B1 (en) *	1997-06-16	2002-04-16	Legerity, Inc.	Phase-locked loop arrangement with fast lock mode
US6174070B1 (en) *	1998-03-02	2001-01-16	Elna Kabushiki Kaisha	Portable lighting instrument having a light emitting diode assembly
MA26618A1 (fr)	1998-04-09	2004-12-20	Smithkline Beecham Corp	Composes et compositions pharmaceutiques pour le traitement du paludisme
US6147070A (en)	1998-06-05	2000-11-14	Facchini; Francesco	Methods and compositions for controlling iron stores to treat and cure disease states
US6083966A (en)	1998-08-31	2000-07-04	University Of Florida	Thiazoline acid derivatives
US6159983A (en)	1998-09-18	2000-12-12	University Of Florida	Method and composition for treatment of inflammatory bowel disease
CN1585639A (zh)	1998-09-21	2005-02-23	佛罗里达大学研究基金会	抗疟疾制剂
US6251927B1 (en) *	1999-04-20	2001-06-26	Medinox, Inc.	Methods for treatment of sickle cell anemia
DE19919336A1 (de)	1999-04-27	2000-11-16	Consortium Elektrochem Ind	Verfahren zur Ringspaltung von Thiazolidinderivaten
DE19948434A1 (de)	1999-10-08	2001-06-07	Gruenenthal Gmbh	Substanzbibliothek enthaltend bicyclische Imidazo-5-amine und/oder bicyclische Imidazo-3-amine
WO2004017959A2 (en)	2002-08-22	2004-03-04	University Of Florida	Antioxidant and radical scavenging activity of synthetic analogs of desferrithiocin
US20040044220A1 (en) *	2002-08-22	2004-03-04	University Of Florida	Antioxidant and radical scavenging activity of synthetic analogs of desferrithiocin
AU2003270473A1 (en) *	2003-09-09	2005-04-27	University Of Florida	Desferrithiocin derivatives and their use as iron chelators
WO2005023310A2 (en)	2003-09-09	2005-03-17	University Of Florida Research Foundation, Inc.	Polyamine-metal chelator conjugates
CA2587558A1 (en)	2004-11-19	2006-05-26	Shiva Biomedical, Llc	Methods of treating erythropoietin-resistance
BRPI0610644B8 (pt) *	2005-04-04	2021-05-25	Univ Florida	composto e composição farmacêutica que compreende tal composto e um veículo ou diluente farmaceuticamente aceitável.
CA2684837A1 (en) *	2006-12-12	2008-10-30	Raymond J. Bergeron, Jr.	Desferrithiocin analogue actinide decorporation agents
NZ579994A (en) *	2007-03-15	2011-09-30	Univ Florida	Desferrithiocin polyether analogues useful in the treatment of pathological conditions responsive to chelation or sequestration of trivalent metal

1998
- 1998-08-31 US US09/144,103 patent/US6083966A/en not_active Ceased
1999
- 1999-08-31 DE DE69929807T patent/DE69929807T2/de not_active Expired - Lifetime
- 1999-08-31 BR BRPI9913441-1B1A patent/BR9913441B1/pt not_active IP Right Cessation
- 1999-08-31 WO PCT/US1999/019691 patent/WO2000012493A1/en not_active Ceased
- 1999-08-31 EA EA200100261A patent/EA200100261A1/ru unknown
- 1999-08-31 AU AU57897/99A patent/AU759851B2/en not_active Ceased
- 1999-08-31 EP EP99945267A patent/EP1109795B1/en not_active Expired - Lifetime
- 1999-08-31 CZ CZ2001711A patent/CZ2001711A3/cs unknown
- 1999-08-31 ES ES99945267T patent/ES2260933T3/es not_active Expired - Lifetime
- 1999-08-31 HU HU0103165A patent/HUP0103165A3/hu unknown
- 1999-08-31 CN CNB998099899A patent/CN100455574C/zh not_active Expired - Fee Related
- 1999-08-31 YU YU21801A patent/YU21801A/sh unknown
- 1999-08-31 AT AT99945267T patent/ATE317392T1/de not_active IP Right Cessation
- 1999-08-31 TR TR2001/00541T patent/TR200100541T2/xx unknown
- 1999-08-31 PL PL99346852A patent/PL346852A1/xx not_active Application Discontinuation
- 1999-08-31 UA UA2001032117A patent/UA57161C2/uk unknown
- 1999-08-31 KR KR1020017002702A patent/KR20010074907A/ko not_active Ceased
- 1999-08-31 NZ NZ509899A patent/NZ509899A/en not_active IP Right Cessation
- 1999-08-31 IL IL14161199A patent/IL141611A0/xx active IP Right Grant
- 1999-08-31 JP JP2000567521A patent/JP4817498B2/ja not_active Expired - Fee Related
- 1999-08-31 CA CA002342210A patent/CA2342210C/en not_active Expired - Fee Related
- 1999-08-31 PT PT99945267T patent/PT1109795E/pt unknown
2000
- 2000-03-20 US US09/531,754 patent/US6521652B1/en not_active Expired - Lifetime
- 2000-03-20 US US09/531,753 patent/US6559315B1/en not_active Expired - Lifetime
- 2000-03-20 US US09/531,755 patent/US6525080B1/en not_active Expired - Lifetime
2001
- 2001-02-22 IL IL141611A patent/IL141611A/en not_active IP Right Cessation
- 2001-02-27 NO NO20011003A patent/NO321028B1/no not_active IP Right Cessation
- 2001-10-17 US US09/981,586 patent/USRE39132E1/en not_active Expired - Lifetime
2002
- 2002-11-20 US US10/300,071 patent/US20030236417A1/en not_active Abandoned
2004
- 2004-09-17 US US10/944,150 patent/US7126004B2/en not_active Expired - Fee Related
2006
- 2006-09-15 US US11/522,299 patent/US7531563B2/en not_active Expired - Fee Related
2009
- 2009-03-27 US US12/383,854 patent/US8008502B2/en not_active Expired - Fee Related
2011
- 2011-04-22 JP JP2011095879A patent/JP5520875B2/ja not_active Expired - Fee Related
2013
- 2013-12-12 JP JP2013257270A patent/JP2014065730A/ja active Pending

Also Published As

Publication number	Publication date
US6525080B1 (en)	2003-02-25
NZ509899A (en)	2003-12-19
BR9913441A (pt)	2001-10-23
JP2011178797A (ja)	2011-09-15
US7531563B2 (en)	2009-05-12
UA57161C2 (uk)	2003-06-16
EP1109795A1 (en)	2001-06-27
US20100094016A1 (en)	2010-04-15
US20030236417A1 (en)	2003-12-25
YU21801A (sh)	2005-07-19
NO321028B1 (no)	2006-02-27
HUP0103165A2 (hu)	2002-01-28
US7126004B2 (en)	2006-10-24
ATE317392T1 (de)	2006-02-15
WO2000012493A1 (en)	2000-03-09
ES2260933T3 (es)	2006-11-01
BR9913441B1 (pt)	2013-10-29
HUP0103165A3 (en)	2003-03-28
JP2002523500A (ja)	2002-07-30
NO20011003L (no)	2001-02-27
CN1313856A (zh)	2001-09-19
DE69929807D1 (de)	2006-04-20
DE69929807T2 (de)	2006-11-02
CN100455574C (zh)	2009-01-28
PL346852A1 (en)	2002-03-11
JP2014065730A (ja)	2014-04-17
KR20010074907A (ko)	2001-08-09
CA2342210C (en)	2009-03-10
US20050033057A1 (en)	2005-02-10
CZ2001711A3 (cs)	2001-09-12
CA2342210A1 (en)	2000-03-09
TR200100541T2 (tr)	2001-11-21
NO20011003D0 (no)	2001-02-27
JP4817498B2 (ja)	2011-11-16
PT1109795E (pt)	2006-06-30
IL141611A (en)	2006-12-31
EP1109795A4 (en)	2002-01-16
USRE39132E1 (en)	2006-06-13
JP5520875B2 (ja)	2014-06-11
US20070238767A1 (en)	2007-10-11
EA200100261A1 (ru)	2001-10-22
US6521652B1 (en)	2003-02-18
AU5789799A (en)	2000-03-21
US6083966A (en)	2000-07-04
AU759851B2 (en)	2003-05-01
US6559315B1 (en)	2003-05-06
US8008502B2 (en)	2011-08-30
HK1035720A1 (en)	2003-04-24
EP1109795B1 (en)	2006-02-08
WO2000012493A9 (en)	2002-04-11

Publication	Publication Date	Title
IL141611A0 (en)	2002-03-10	Thiazoline acid derivatives
NZ330860A (en)	1999-11-29	Method of inhibiting photoaging of skin
ZA9811023B (en)	2000-06-02	Cast iron inoculant and method for production of cast iron inoculant.
EP1123411A4 (en)	2002-05-02	ENZYMATIC METHODS FOR MEASURING LYSOPHOSPHOLIPIDS AND PHOSPHOLIPIDS LINKED TO CONDITIONS
IL142824A0 (en)	2002-03-10	Lipoic acid derivatives and their use in treatment of disease
DK119495A (da)	1996-04-26	Alkaliske zink- og zinklegeringselektropletteringsbade og -fremgangsmåder
DE69432298D1 (de)	2003-04-24	System zur diagnostik und behandlung der prostata und der harnwege
FI955709L (fi)	1996-01-03	Indolokarbatsolijohdannaisten käyttö eturauhasen patologisten tilojen hoidossa
PH31600A (en)	1998-11-03	Methods of inhibiting atrophy of the skin and vagina.
ZA991053B (en)	1999-08-11	Method and composition for treatment of inflammatory conditions.
GB2335935B (en)	2002-10-16	Method for harvesting animals living in or on the seabed and apparatus therefor
AU3470399A (en)	1999-10-18	Agents and methods for modulation of zinc transfer by metallothionein
AU3167993A (en)	1993-07-19	Ligands and binding partner for treatment and diagnosis of inflammatory conditions
AU4150999A (en)	2000-01-05	Method and kit for early diagnosis of cancer
CA2293808A1 (en)	1998-12-17	Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases
MXPA99011362A (es)	2004-09-01	Empleo de 2-mercapto-piridin-n-oxido.
DE69833210D1 (de)	2006-04-06	Radiotherapeutische vorrichtung zur behandlung der prostata
ZA992192B (en)	1999-11-08	Humectant and lubricant solution for ophthalmic use.
EP0864876A4 (en)	2000-05-10	DEVICE AND METHOD FOR ESTIMATING THE REMAINING LIFE OF A BATTERY
AU3178697A (en)	1998-01-14	Method and kit for the diagnosis of troponin i
ATA115194A (de)	1997-07-15	Entschwefelungsmittel für roheisen- und gusseisenschmelzen
NO974609D0 (no)	1997-10-06	Azolforbindelser med antimykotisk aktivitet for anvendelse på mennesker og dyr
GR1002710B (el)	1997-06-04	Μεθοδος κατεργασιας μονοινου νηματος αλιειασ.πετονια ψαρεματος σε διατομες (απο νο 20 -200).
Popescu et al.	1994	SOME PROPERTIES OF THE alpha-Fe 2 O 3/ELECTROLYTE INTERFACE; MODELLING THROUGH AN EQUIVALENT CIRCUIT
GB2275780B (en)	1996-10-23	Methods of measuring and controlling activity of zinc phosphate treatment solution

Legal Events

Date	Code	Title	Description
2007-07-06	FF	Patent granted
2007-07-06	KB	Patent renewed